MedTrace Logo

Improving the Outcomes of Peritoneal Dialysis (PD) Catheter Insertion

NCT04034628 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2320

Last updated 2019-07-26

No results posted yet for this study

Summary

Peritoneal dialysis (PD) is actively promoted as the preferred form of dialysis for patients with kidney failure. However, 1 in 5 patients will experience a signification catheter insertion-related PD catheter complication in the first 6 months following insertion. Little is known about the patient-, operator-, and center-level factors that influence PD catheter complications. There is a need to identify key modifiable practices to focus randomized trials and quality improvement efforts. We will leverage prior funding, a custom-built data collection platform, pilot data, and a group of engaged stakeholders, partners, and knowledge users to: a) Determine if method of insertion is associated with PD catheter complications b) Identify operator/center characteristics and practices associated with PD catheter complications c) Use a data-driven approach to achieve expert consensus on optimal practices for PD catheter insertion and care.

Conditions

  • Peritoneal Dialysis Access Failure
  • Peritoneal Dialysis Complication

Interventions

DEVICE

Peritoneal Catheter Insertion - Laparoscopic

Insertion of a Peritoneal Catheter into the abdomen for the purposes of treating kidney failure

DEVICE

Peritoneal Catheter Insertion - Percutaneous

Insertion of a Peritoneal Catheter into the abdomen for the purposes of treating kidney failure

Sponsors & Collaborators

  • Sunnybrook Health Sciences Centre

    lead OTHER

Principal Investigators

  • Matthew Oliver, MD MHS · University of Toronto

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2022-12-31
Completion
2024-03-30
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04034628 on ClinicalTrials.gov